Shanghai Haohai Biological Technology Co., Ltd. (6826.HK) HKSE

26.30

+0.02(+0.08%)

Updated at September 30 11:22AM

Currency In HKD

Valuation

Market Cap5.83B
Enterprise Value3.65B
P/E Ratio28.57
PEG Ratio-2.83
Price/Sales Ratio4.02
Price/Book Ratio2.08
Enterprise/Revenue3.23
Enterprise/EBITDA13.64

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterMarch 31, 2025

Profitability

Profit Margin0.16
Operating Margin0.14

Management Effectiveness

Return On Assets0.06
Return On Equity0.07

Income Statement

Revenue2.68B
Revenue/Share11.52
Gross Profit1.87B
EBITDA665.04M
Net Income420.45M
Diluted EPS1.8

Balance Sheet

Total Cash2.66B
Total Cash/Share11.55
Total Debt452.51M
Total Debt/Equity0.08
Current Ratio4.25
Book Value Per Share25.91

Price History

52-Week Change-27.57
52-Week High42.95
52-Week Low21.7
Moving Average 50 Days28.41
Moving Average 200 Days26.54

Statistics

Average Volume610,394
Shares Outstanding446.96M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate1
Trailing Annual Dividend Yield1.95
Payout Ratio0.97
Last Split Factor7:5
Last Split DateJune 06, 2024